Panacea Biotec donates 125,000 doses of Easyfive-TT to Ministry of Health, Republic of Cuba for use in the National Health System

Panacea Biotec on humanitarian grounds has donated 125,000 single dose vials (SDVs) of its WHO Prequalified Pentavalent vaccine, Easyfive-TT, to the Ministry of Health of Republic of Cuba for use in Cuba National Health System speciflcallv in the expanded immunization program due to current ongoing shortage of the wP based Pentavalent Vaccine in Cuba.

Speaking on the occasion, Dr. Rajesh Jain, Chairman & Managing Director, Panacea Biotec, said "Panacea Biotec believes in giving a chance for Better health. The Government has time and again emphasized "Vasudhaiv Kutumbakam" meaning the "World is one Family". Our donation is a small step in our continuous strive for Indian science and capabilities for the benefit of all."

Speaking on the occasion Mr. Alejandro Simancas Marin, Ambassador of Republic of Cuba said By virtue ofthe above, the Embassy of the Republic of Cuba on behalf of the Government and the Cuban people wishes to express its deep gratitude to Panacea Biotec, its managements and specialists for this gesture of solidarity. Without a doubt" this donation will allow the continuation of the cycle of vaccination for children foreseen within the national immunization program carried out by the Ministry of Public Health of Cuba and that it covers free of charge to all the children of Cuba.

Panacea Biotec and the Cuban institutions in the biopharmaceutical industry maintain a working and collaborative relationship that goes beyond commercial interests and has resulted in mutual benefit and has highlighted the opportunities and potential that exists in this sector for bilateral collaboration.

This gesture of solidarity of Panacea Biotec reflects the historical ties of friendship and collaboration between Cuba and India, which celebrated its 63rd Anniversary on last January 12. They are also an example of the south-south collaboration between our countries and the effort they make for the social development of their peoples, especially after the challenges involved in confronting the Covid pandemic.

This is an example of solidarity and humanism in favour of health in Cuba, and especially of its children, and contrasts with the policy of blockade imposed on us and affect us so much.

Cuba sincerely thanks this friendly hand of India, and we are proud of the friendship we share and the commitment to continue working together to strengthen it for the good of our people's and an example of collaboration.

As the National Hero of Cuba, Jose Marti" would express: great works can only be possible with great friends.

Any missed wP-Pentavalent vaccination dose would imply vulnerability to new born, infants and children to morbid disease conditions like Diphtheria, Whooping Cough, Neonatal Tetanus, Hepatitis B, invasive Pneumonia or Meningitis due to Haemophilius Influenza Type B. These are commonest vaccine preventable diseases in new born, infants and children. It is, therefore, imperative that such a vaccination strategy is executed and implemented at all times without any break in the immunization schedule.

Center for Genetic Engineering and Biotechnology (CIGB) and the Finlay Vaccine Institute (IFV) are leading vaccine producers in Cuba. During the last two years, their production capacities were dedicated to the production of Covid-19 vaccine and pharmaceutical products due to Covid-19 Pandemic which led to the current shortage of Pentavalent Vaccine in Cuba.

Paediatric vaccination plays an important role to achieve Sustainable Development Goals (SDGs) set by the United Nations, in particular the target to reduce under-five mortality rate to less than 25 per 1000 live births.

We have been privileged to partner with Center for Genetic Engineering & Biotechnology for over 20 years and provide sustainable supplies of our vaccines globally to enable people to live healthier and live longer. We are happy to support our friends in their time of need and we continue to fight and minimise the impact of the Covid-19 pandemic.

Shares of Panacea Biotec Limited was last trading in BSE at Rs. 136.15 as compared to the previous close of Rs. 135.95. The total number of shares traded during the day was 14417 in over 625 trades.

The stock hit an intraday high of Rs. 136.95 and intraday low of 135.00. The net turnover during the day was Rs. 1962302.00.

Source : Equity Bulls

Keywords

PanaceaBiotec INE922B01023 Donation SingleDoseVials PentavalentVaccine WHOPrequalified EasyfiveTT Cuba